What does the FDA Purple Book provide?

What does the FDA Purple Book provide?

• A. Guidance on biosimilar development timelines
• B. Information regarding biosimilar and interchangeable biological products approved under the Public Health Service Act
• C. Regulations for biologics labeling naming conventions
• D. Biologic product patent verification

Answer: (B)

The FDA Purple Book is a registry of biological products that have been approved as biosimilars or interchangeable biologics under the Public Health Service Act, including information about the reference product and any exclusivity statuses. This makes it the authoritative source for identifying which products are biosimilar or interchangeable and how they relate to their reference biologics. It does not provide development timelines, regulate labeling or naming conventions, or verify patents, which is why it’s the specific resource for biosimilar and interchangeability information under the PHS Act.

The FDA Purple Book is a registry of biological products that have been approved as biosimilars or interchangeable biologics under the Public Health Service Act, including information about the reference product and any exclusivity statuses. This makes it the authoritative source for identifying which products are biosimilar or interchangeable and how they relate to their reference biologics. It does not provide development timelines, regulate labeling or naming conventions, or verify patents, which is why it’s the specific resource for biosimilar and interchangeability information under the PHS Act.